Last reviewed · How we verify
NCT04915235: PAPCAT
Prevalence and Prognosis of Cardiac Amiloidosis in Turkey
trial testing Algorithm in Cardiac Amyloidosis in 2,087 participants. Status unknown.
31 December 2025
Quick facts
| Lead sponsor | Turkish Society of Cardiology |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,087 |
| Start date | 18 September 2020 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Algorithm
Conditions studied
- Cardiac Amyloidosis — all drugs for Cardiac Amyloidosis →
Sponsor
Turkish Society of Cardiology
Who can join
18 and older, any sex, with Cardiac Amyloidosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with left ventricular hypertrophy are further examined according to an algorithm to check if they have a cardiac amyloidosis
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04915235
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Algorithm
Trials testing the same drug.
- NCT05779839 — A Study of Caregiver Connections Via Technology in Dementia · NA · active not recruiting
- NCT05218525 — Testing a Prediction Algorithm Into a Running Telehealth System for Patients With COPD · NA · completed
- NCT04814199 — Use of Standardized Algorithm for the Management of Epidural Analgesia for Labor and Delivery · completed
Other recruiting trials for Cardiac Amyloidosis
Currently open trials in the same condition.
- NCT07232459 — [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis · recruiting
- NCT06788535 — Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis · Phase 3 · active not recruiting
- NCT06458374 — ATTR Cardiac Amyloidosis in a Selected Population · recruiting
- NCT06427304 — Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure · recruiting
- NCT06907836 — Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine · recruiting
Other Turkish Society of Cardiology trials
Trials by the same sponsor.
- NCT04069598 — Statin Intolerance in Patients With Myocardial Infarction · unknown
- NCT04241770 — TURKish Acute Myocardial Infarction Registry · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04915235 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Turkish Society of Cardiology
- Last refreshed: 7 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04915235.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing